Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Tracheostomy in intensive care unit patients can be performed without bleeding complications in case of normal thromboelastometry results (EXTEM CT) despite increased PT-INR: a prospective pilot study.

Durila M, Lukáš P, Astraverkhava M, Beroušek J, Zábrodský M, Vymazal T.

BMC Anesthesiol. 2015 Jun 10;15:89. doi: 10.1186/s12871-015-0073-1.

2.

Prophylactic plasma and platelet transfusion in the critically Ill patient: just useless and expensive or even harmful?

Görlinger K, Saner FH.

BMC Anesthesiol. 2015 Jun 9;15:86. doi: 10.1186/s12871-015-0074-0.

3.

Successful implementation of a packed red blood cell and fresh frozen plasma transfusion protocol in the surgical intensive care unit.

Szpila BE, Ozrazgat-Baslanti T, Zhang J, Lanz J, Davis R, Rebel A, Vanzant E, Gentile LF, Cuenca AG, Ang DN, Liu H, Lottenberg L, Marker P, Zumberg M, Bihorac A, Moore FA, Brakenridge S, Efron PA.

PLoS One. 2015 May 26;10(5):e0126895. doi: 10.1371/journal.pone.0126895. eCollection 2015.

4.

Plasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational study.

Soundar EP, Besandre R, Hartman SK, Teruya J, Hui SK.

J Intensive Care. 2014 Nov 29;2(1):64. doi: 10.1186/s40560-014-0064-1. eCollection 2014.

5.

Moderate elevations in international normalized ratio should not lead to delays in neurosurgical intervention in patients with traumatic brain injury.

Rowell SE, Barbosa RR, Lennox TC, Fair KA, Rao AJ, Underwood SJ, Schreiber MA.

J Trauma Acute Care Surg. 2014 Dec;77(6):846-50; discussion 851. doi: 10.1097/TA.0000000000000459.

6.

Complications following an unnecessary peri-operative plasma transfusion and literature review.

Raval JS, Waters JH, Triulzi DJ, Yazer MH.

Asian J Transfus Sci. 2014 Jul;8(2):139-41. doi: 10.4103/0973-6247.137458.

7.

Transfusion and coagulation management in liver transplantation.

Clevenger B, Mallett SV.

World J Gastroenterol. 2014 May 28;20(20):6146-58. doi: 10.3748/wjg.v20.i20.6146. Review.

8.

Management of dabigatran-induced bleeding: expert statement.

Fries D, Giurea A, Gütl M, Halbmayer WM, Kozek-Langenecker S, Pachucki A, Roithinger F, Steinlechner B, Thaler H, Weltermann A.

Wien Klin Wochenschr. 2013 Nov;125(21-22):721-9. doi: 10.1007/s00508-013-0430-3. Epub 2013 Nov 12.

9.

Plasma in the PICU: why and when should we transfuse?

Labarinas S, Arni D, Karam O.

Ann Intensive Care. 2013 Jun 2;3(1):16. doi: 10.1186/2110-5820-3-16.

10.

Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion.

Collins CL, Scott JP, Panepinto JA, Punzalan RC.

J Pediatr Hematol Oncol. 2013 Jul;35(5):e226-8. doi: 10.1097/MPH.0b013e3182830c25.

11.

Complications following an unnecessary peri-operative plasma transfusion and literature review.

Raval JS, Waters JH, Triulzi DJ, Yazer MH.

Korean J Hematol. 2012 Dec;47(4):298-301. doi: 10.5045/kjh.2012.47.4.298. Epub 2012 Dec 24.

12.

Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy.

Görlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schöchl H.

Transfus Med Hemother. 2012 Apr;39(2):104-113. Epub 2012 Mar 8.

13.

Adverse effects of plasma transfusion.

Pandey S, Vyas GN.

Transfusion. 2012 May;52 Suppl 1:65S-79S. doi: 10.1111/j.1537-2995.2012.03663.x. Review.

14.

Transfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial.

Müller MC, de Jonge E, Arbous MS, Spoelstra-de Man AM, Karakus A, Vroom MB, Juffermans NP.

Trials. 2011 Dec 23;12:266. doi: 10.1186/1745-6215-12-266.

15.

The conundrum of persistent inappropriate use of frozen plasma.

Tinmouth AT, McIntyre L.

Crit Care. 2011;15(3):160. doi: 10.1186/cc10215. Epub 2011 May 25.

16.

Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party.

Blood Transfus. 2011 Apr;9(2):189-217. doi: 10.2450/2011.0075-10. No abstract available.

17.

A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.

Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D; Intensive Care Study of Coagulopathy (ISOC) investigators.

Crit Care. 2011;15(2):R108. doi: 10.1186/cc10129. Epub 2011 Apr 5.

18.

The how's and why's of evidence based plasma therapy.

Yazer MH.

Korean J Hematol. 2010 Sep;45(3):152-7. doi: 10.5045/kjh.2010.45.3.152. Epub 2010 Sep 30.

19.

An audit of fresh frozen plasma usage and effect of fresh frozen plasma on the pre-transfusion international normalized ratio.

Shinagare SA, Angarkar NN, Desai SR, Naniwadekar MR.

Asian J Transfus Sci. 2010 Jul;4(2):128-32. doi: 10.4103/0973-6247.67024.

20.

Rationalizing the clinical use of frozen plasma.

Pinkerton PH, Callum JL.

CMAJ. 2010 Jul 13;182(10):1019-20. doi: 10.1503/cmaj.081933. Epub 2010 Mar 15. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk